Peripheral T Cell Lymphoma Clinical Trials in Tianjin, Tianjin Municipality
6 recruitingTianjin, Tianjin Municipality, China
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Evaluate the Safety and Clinical Activity of HH2853
Advanced Solid TumorPeripheral T Cell LymphomaFL Lymphoma+1 more
Haihe Biopharma Co., Ltd.254 enrolled25 locationsNCT04390737
Recruiting
Phase 1Phase 2
Linperlisib Combined With Chidamide in Patients With PTCL
Peripheral T Cell Lymphoma
Yanyan Liu134 enrolled6 locationsNCT06421948
Recruiting
Phase 3
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
Peripheral T Cell Lymphoma
Dizal Pharmaceuticals218 enrolled50 locationsNCT07234162
Recruiting
Phase 2
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Diffuse Large B Cell LymphomaPeripheral T Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China115 enrolled1 locationNCT06244368
Recruiting
Phase 1
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
Peripheral T Cell LymphomaCutaneous T Cell Lymphoma (CTCL)NHL (Non-Hodgkin Lymphoma)
Tianjin Medical University Cancer Institute and Hospital24 enrolled1 locationNCT06914037
Recruiting
Phase 2
Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma
Peripheral T Cell LymphomaEpigenetic Repression
Institute of Hematology & Blood Diseases Hospital, China37 enrolled1 locationNCT05958719